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Resumo
Introdução: Dados nacionais sobre diálise 
crônica são essenciais para o planejamento 
do tratamento de tal enfermidade. Objetivo: 
Apresentar dados do Censo da Sociedade 
Brasileira de Nefrologia (SBN) sobre os 
pacientes com doença renal crônica que 
estavam em diálise de manutenção em 1 
de julho de 2010. Métodos: Levantamento 
dos dados de unidades de diálise de todo o 
país. A coleta de dados foi feita utilizando 
questionário preenchido online pelas uni-
dades de diálise do Brasil cadastradas na 
SBN. Resultados: Das unidades consulta-
das, 340 (53,3%) responderam ao Censo. 
A partir dessas respostas foram feitas esti-
mativas nacionais para a população em di-
álise. Em julho de 2010, o número estima-
do de pacientes em diálise foi de 92.091. As 
estimativas nacionais das taxas de preva-
lência e de incidência de insuficiência renal 
crônica em tratamento dialítico foram de 
483 e 100 pacientes por milhão da popula-
ção, respectivamente. O número estimado 
de pacientes que iniciaram tratamento em 
2010 foi 18.972. A taxa anual de morta-
lidade bruta foi de 17,9%. Dos pacientes 
prevalentes, 30,7% tinham idade igual ou 
superior a 65 anos; 90,6% estavam em 
hemodiálise e 9,4% em diálise peritoneal; 
35.639 (38,7%) estavam em fila de espe-
ra para transplante; 28% eram diabéticos; 
34,5% tinham fósforo sérico > 5,5 mg/dL 
e 38,5%, hemoglobina <  11 g/dL. O cate-
ter venoso era usado como acesso vascular 
em 13,6% dos pacientes em hemodiálise. 
Conclusões: A prevalência de pacientes em 
diálise tem apresentado aumento progres-
sivo. Os dados dos indicadores da qualida-
de diálise de manutenção melhoraram em 
relação a 2009 e destacam a importância 
do censo anual para o planejamento da as-
sistência dialítica.
AbstRAct
Introduction: National chronic dialysis 
data are fundamental for treatment plan-
ning. Objective: To report data of the 
annual survey of the Brazilian Society of 
Nephrology about patients with chron-
ic renal failure who were on dialysis in 
1 July, 2010. Methods: A national survey 
based on data from the country`s dialysis 
centers. Data collection was performed 
by using a questionnaire filled out on-
line by the dialysis centers. Results: 340 
(53.3%) centers answered the question-
naire. National data were estimated for 
the overall dialysis population. In July 
2010, the estimated total number of pa-
tients on dialysis was 92,091. The esti-
mated prevalence and incidence rates of 
end-stage chronic kidney disease patients 
on maintenance dialysis were 483 and 
100/million population, respectively. The 
estimated number of patients starting a 
dialysis program in 2010 was 18,972. The 
annual crude mortality rate was 17.9%. 
Of those on maintenance dialysis, 30.7% 
were aged 65 years or older, 90.6% were 
on hemodialysis and 9.4% on peritoneal 
dialysis, 35,639 (38.7%) were on a kidney 
transplant waiting list, 28% were diabet-
ics, 34.5% had serum phosphorus levels 
> 5.5 mg/dL, and 38.5% had hemoglo-
bin levels < 11 g/dL. Vascular access was 
through a venous catheter in 13.6% of 
the hemodialysis patients. Conclusions: 
The number of end-stage kidney disease 
patients on maintenance dialysis is in-
creasing in Brazil. Data concerning the 
indicators of the quality of maintenance 
dialysis improved compared to the prior 
year, and they highlight the importance 
of the census to guide chronic dialysis 
therapy.
2010 report of the Brazilian dialysis census
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Number of centers with a chronic dialysis program 638
Centers which responded 340 (53,3%)
Type of center (private, philanthropic, public) 76%/16%/8%
Type of Center (satellite, hospital) 50%/50%
Number of patients in the 340 centers which responded 49,077
Estimated total number of patients on dialysis in the country 92,091
Brazilian population in January 2010 (IBGE) 190,73 million
Table 1
general data Of the dialysis centers, answers tO the census and number Of patients – 2010 
census
IntRoductIon
Since the beginning of this century, the Brazilian 
Nephrology Society (Sociedade Brasileira de 
Nefrologia, SBN) has conducted an annual census 
of patients with end-stage renal disease (ESRD) on 
dialysis therapy, from information provided by the 
registered dialysis centers.  This information has 
proved essential for improved knowledge about the 
patients on chronic dialysis in the country and for bet-
ter planning of their care.  This initiative has counted 
on the voluntary collaboration of the dialysis centers 
throughout the country.  This is a report on the pa-
tients on dialysis in 1 July, 2010. 
methods
In July 2010, we conducted a survey of the ESRD pa-
tients on outpatient dialysis in all dialysis centers reg-
istered with the SBN.  During the second semester of 
2010, a form with the survey questions was available 
at the SBN electronic website, the dialysis centers be-
ing requested to fill it in and send it online to the SBN. 
Up to December 2010, deadline for information ar-
rival, monthly reminders were sent to the units which 
had not responded.  Whenever necessary, the data 
were obtained or confirmed through a telephone call 
from the SBN to the head of the center.  The questions 
about some sociodemographic, clinical, laboratory 
and treatment data referred to patients on dialysis in 
1 July, 2010.  Data concerning mortality and admis-
sion of new patients to the dialysis program referred 
to July 2010 and were estimated for the year.
Of the 682 dialysis centers registered with the 
SBN in July 2010, 638 had an active chronic dialysis 
program and 340 (53.3%) answered the survey and 
had their data analyzed (Table 1).  Information was 
obtained from 49,077 patients on dialysis in the 340 
participating units.  Because the data were grouped 
for each center and not individualized to each patient, 
they must be interpreted as the means of patients` 
characteristics and treatment practices of each unit. 
National data were estimated by taking into account 
the expected figures from the centers which did not 
answer the survey, calculated as the expected patient 
number mean, according to their regional location. 
The national and regional population estimates, used 
in the prevalence and incidence calculations, were 
obtained from the Brazilian Geography and Statistics 
Authority (Instituto Brasileiro de Geografia e 
Estatística - IBGE) January 2010 data.   Grouped data 
were used to estimate the rates of off-target patients 
for recommended1,2 dialysis dose (assessed through 
Kt/V or urea reduction ratio) and serum levels of al-
bumin, phosphorus, parathyroid hormone (PTH) and 
hemoglobin. 
Results
Figure 1 shows the distribution of the centers which 
answered the survey, according to region.  The rate 
of units which answered was similar throughout the 
country, with most units situated in the South-East, 
followed by the South and North-East.  Table 2 shows 
data concerning the funding source responsible for 
reimbursement of chronic dialysis maintenance treat-
ment in Brazil.  Of the 340 centers, 92.4% received 
reimbursement from the Brazilian Unified Health 
System (Sistema Único de Saúde – SUS), and 77.6% 
received reimbursements from other funding schemes. 
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85.8% of the patients were SUS-reimbursed, and 
14.2% were reimbursed by private health insurance.
Figure 2 shows the total estimate of patients on di-
alysis in Brazil, during the 2000-2010 period.  There 
has been a gradual increase from 42,695 in 2000 to 
92,091 in 2010. Over half of these patients lived in the 
South-East.  The prevalence rate of dialysis treatment 
in 2010 was 483 patients/million population, ranging 
from 265/million in the North and 591/million in the 
South-East (Figure 3).  The estimated number of pa-
tients starting treatment in 2010 in Brazil was 18,972 
(incidence rate: 99.5/million). 
1.6% of the patients were aged 18 years or under, and 
30.7% were 65 or over. 57% of the total were male.
In July 2010, 90.6% of patients on chronic dialy-
sis received hemodialysis (HD), and 9.4% peritoneal 
dialysis (PD), automated peritoneal dialysis (APD) 
being the predominant modality.  Table 3 shows pa-
tient distribution according to dialysis modality and 
funding source; compared to those who were SUS-
reimbursed, a higher rate of patients reimbursed by 
another health insurance scheme was on daily HD 
and APD.  When the funding source was the SUS, 
the rate of patients on PD was lower than when 
funding came from elsewhere (9.0% and 12.3%, 
respectively).
The most frequent primary renal diseases were: 
hypertension (35%) and diabetes (28%), as can be 
seen in Figure 4.
Hepatitis-C (HCV) and hepatitis-B (HBV) sero-
positivity rates, which were 5.8 and 1.1%, respective-
ly, have been declining.  HIV seropositivity rate was 
1.2%.  In 2009, HCV, HBV and HIV seropositivity 
rates were 6.9, 1.3 and 0.6%, respectively.
The estimated rate of HD patients with ac-
cess through a central venous catheter (temporary 
or permanent) was 13.6%. Of the 49,077 patients, 
the monthly hospitalization rate was 5.3% in July 
Figure 1. Centers which responded to the census 
(n = 340), according to region; 2010 Census.
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Figure 3. Estimated prevalence of patients on dialysis 
in Brazil, according to region; 2010 Census.
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Figure 2. Estimated total numbers of patients on 
dialysis treatment in the country, according to the 
year; 2010 Census. 
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2010. As for the recommended laboratory indices,1,2 
Figure 5 shows that of those on HD, 19.2% had a 
Kt/V < 1.2 or urea reduction ratio < 65%; 13.1% had 
serum albumin levels < 3.5 g/dL; 34.5% serum phos-
phorus > 5.5 mg/dL and; 28.1%, PTH > 300 pg/mL. 
14.2% had PTH < 100 pg/mL and 38.5% had hemo-
globin < 11 g/dL.
Figure 6 shows the rates of use of some selected 
medications: 81% were on erythropoietin; 53% on 
intravenous iron supplementation; 32% on vitamin D 
and 36% on sevelamer phosphate binder. 
The estimated number of patients enrolled in a kid-
ney transplant waiting list in July 2010 was 35,639, 
equivalent to a 38.7% (35,639/92,091) rate. 
The estimated number of deaths in 2010 was 
16,505, corresponding to a 17.9% crude mortal-
ity rate (with the population on dialysis in 1 July as 
the denominator) during the year.  This rate falls to 
14.9% when the patients at risk in the year (who were 
on dialysis during the year) are included in the de-
nominator.  Figure 7 shows the crude mortality rates 
from 2008 to 2010.
dIscussIon
This study, which was based on data from the July 
2010 Brazilian Dialysis Census, provides an insight 
into the status of the dialysis centers and of the pa-
tients on chronic dialysis treatment in Brazil.  The 
results were based on data from the centers which 
responded to the survey (approximately 50% of the 
centers).  This rate is lower than that of 2009 (60%).3 
This was due, in part, to the method of data collec-
tion, which became exclusively online in the last year, 
and which still needs improving. 
The proportion of centers which responded is 
quite similar to the total distribution of dialysis cen-
ters per region, which leads us to assume a national 
generalization of the results.  The estimates suggest an 
increased number (and an increased prevalence rate) 
of patients on dialysis in 2010, in relation to previous 
years, reaching 6.5%/year for the last 4 years.  Yearly 
estimates must be interpreted with caution though, 
because of the variable response rate and variations 
in the month the data were collected.  In 2009, for 
Modality
SUS 
n (%)
Non-SUS 
n (%)
Total 
n (%)
Conventional HD 38,048 (90.3) 5,958 (85.7) 44,003 (89.7)
Daily HD (> 4/week) 300 (0.7) 145 (2.1) 445 (0.9)
CAPD 1,784 (4.2) 217 (3.1) 2,001 (4.1)
APD 1,888 (4.5) 627 (9.0) 2,515 (5.1)
IPD 104 (0.2) 9 (0.1) 113 (0.2)
Total 42,121 (100) 6,956 (100) 49,077 (100)
Table 3 distributiOn Of patients accOrding tO dialysis mOdality and funding sOurce – 2010 census
Figure 4. Primary diagnosis of patients on dialysis; 
2010 Census.
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Figure 5. Rates of patients with off-target laboratory 
results 2009-2010; 2010 Census.
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Figure 6. Rates of patients on some selected medica-
tions 2009-2010; 2010 Census.
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Figure 7. 2008-2010 crude mortality rate; 2010 
Census.
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example, the data referred to January, whereas from 
2010 onwards, the date was set in July. 
The global prevalence rate of patients on dialy-
sis (483/million) should be added to that of patients 
with a functioning transplant, so as to obtain the 
actual rate of renal replacement therapy, which may 
reach 650-700/million, depending on the non-con-
firmed number of patients with a functioning kidney 
graft.  This latter rate is lower than those of Chile, 
Uruguay and developed European nations (around 
1,000/million) and of North America (1,750/mil-
lion), in 2008.4 Because of wide regional varia-
tion, however, the South-East rate must be close to 
that of developed nations.  About 19,000 patients 
were started on chronic dialysis treatment in 2010, 
a figure to which pre-emptive transplant recipients 
should be added, so that a more accurate incidence 
rate could be calculated.  The latter does not seem 
to be far from that observed in more developed 
countries, with the exception of the United States 
(362/million) and Japan (288/million).4
The 90.6% rate of patients on maintenance HD 
is similar to those from previous censuses, with a 
highlight on a higher rate of patients on APD among 
those subsidized by a supplementary health scheme 
and on the incipient contribution of daily HD as a 
therapeutic modality.  Hypertensive nephropathy 
and diabetic nephropathy are the main primary dis-
eases.  HCV and HBV seropositivity has been declin-
ing each year.  Conversely, the observation that HIV 
seropositivity has increased merits follow-up.  There 
was a decrease in the number of off-target patients 
according to international guidelines for laboratory 
results,1,2 compared with the previous year.  Anemia 
rate reached 38%, although most patients receive 
erythropoietin and intravenous iron supplementa-
tion.  The recent recommendation of lower hemo-
globin target values for this population may attenu-
ate this indicator.  The high rate of patients with 
anemia and higher-than-recommended phosphorus 
and PTH levels has also been observed in developed 
European countries, the United States and Japan.5,6 
The inadequacy of mineral balance found occurs in 
spite of the high rate of patients on sevelamer phos-
phate binder (36%) and vitamin D (32%), the latter 
showing a decrease in relation to 2009.  Crude mor-
tality rate increased compared with previous years, 
which should be confirmed on future follow-up.  In 
spite of this increase, the rate remains lower than 
that for the population on maintenance dialysis in 
the United States.4 
Generalization of these findings must be carefully 
made, because of the rate of responding centers, the 
technique of grouped data collection and the lack of 
validation of the answers received.
conclusIons
The SBN census is an important instrument to know 
dialysis treatment in Brazil, providing information for 
the improved care of end-stage chronic kidney disease 
patients and for planning of the national chronic di-
alysis treatment policy. 
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